Company: LENZ
Filing Date: 2025-07-31
Form Type: 8-K
Source: 0001815776-25-000059
Chunk: 0

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-07-31
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

OnJuly 31, 2025, LENZ Therapeutics, Inc. issued a press release announcing the approval of LNZ100 in the United States by the U. S. Food and Drug Administration. The press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference, except that the information contained on the website referenced in the press release is not incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.